Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Curcumin, and Celecoxib in Metastatic Colon Cancer
NCT00295035Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Mar 2006
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 3 trial of curcumin in colon cancer, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
curcumin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00295035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00295035.